| scholarly article | Q13442814 |
| P50 | author | Marian Loveday | Q55540234 |
| Tarylee Reddy | Q61985975 | ||
| P2093 | author name string | A Voce | |
| B Margot | |||
| I Master | |||
| J Brust | |||
| K Wallengren | |||
| N Padayatchi | |||
| K Chaiyachati | |||
| P2860 | cites work | Culture conversion among HIV co-infected multidrug-resistant tuberculosis patients in Tugela Ferry, South Africa | Q21562122 |
| Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru | Q28202372 | ||
| Community-based treatment of multidrug-resistant tuberculosis in Lima, Peru: 7 years of experience | Q28271208 | ||
| Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa | Q28272340 | ||
| Early outcomes of MDR-TB treatment in a high HIV-prevalence setting in Southern Africa | Q28476241 | ||
| Outcomes of multi-drug resistant tuberculosis (MDR-TB) among a cohort of South African patients with high HIV prevalence | Q28479241 | ||
| HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response | Q30397119 | ||
| The whole is greater than the sum of the parts: recognising missed opportunities for an optimal response to the rapidly maturing TB-HIV co-epidemic in South Africa | Q33483082 | ||
| Improved early results for patients with extensively drug-resistant tuberculosis and HIV in South Africa. | Q33794794 | ||
| Experiences in conducting multiple community-based HIV prevention trials among women in KwaZulu-Natal, South Africa | Q33848578 | ||
| Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study | Q34707237 | ||
| Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis. | Q36170956 | ||
| What kind of randomized trials do we need? | Q37186087 | ||
| Methodological issues in the design of clinical trials for the treatment of multidrug-resistant tuberculosis: challenges and opportunities. | Q38430474 | ||
| Clinical outcomes of Estonian patients with primary multidrug-resistant versus drug-susceptible tuberculosis | Q43440135 | ||
| Decentralised management of drug-resistant tuberculosis (MDR- and XDR-TB) in South Africa: an alternative model of care | Q44436955 | ||
| Community-based treatment for multidrug-resistant tuberculosis in rural KwaZulu-Natal, South Africa. | Q46339395 | ||
| Integrated tuberculosis and HIV care in a resource-limited setting: experience from the Martin Preuss centre, Malawi. | Q46985317 | ||
| Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months | Q70642870 | ||
| HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality | Q84734382 | ||
| Treatment of multidrug-resistant tuberculosis: definition of the outcome 'failure' | Q95825888 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | South Africa | Q258 |
| KwaZulu-Natal | Q81725 | ||
| P304 | page(s) | 209-215 | |
| P577 | publication date | 2012-02-01 | |
| P1433 | published in | International Journal of Tuberculosis and Lung Disease | Q15767020 |
| P1476 | title | Comparing early treatment outcomes of MDR-TB in decentralised and centralised settings in KwaZulu-Natal, South Africa | |
| P478 | volume | 16 |
| Q48024289 | A diagonal approach to building primary healthcare systems in resource‐limited settings: women‐centred integration of HIV/AIDS, tuberculosis, malaria, MCH and NCD initiatives |
| Q35719006 | A hospital-based tuberculosis focal point to improve tuberculosis care provision in a very high burden setting |
| Q34749709 | A pilot study of an mHealth application for healthcare workers: poor uptake despite high reported acceptability at a rural South African community-based MDR-TB treatment program |
| Q35144014 | Association between health systems performance and treatment outcomes in patients co-infected with MDR-TB and HIV in KwaZulu-Natal, South Africa: implications for TB programmes |
| Q39504043 | Basic research at the epicenter of an epidemic |
| Q35072895 | Community-based care vs. centralised hospitalisation for MDR-TB patients, KwaZulu-Natal, South Africa |
| Q53041364 | Community-based management versus traditional hospitalization in treatment of drug-resistant tuberculosis: a systematic review and meta-analysis |
| Q28554655 | Cost-Effectiveness of Community-Based TB/HIV Screening and Linkage to Care in Rural South Africa |
| Q57027083 | Decentralized, Community-Based Treatment for Drug-Resistant Tuberculosis: Bangladesh Program Experience |
| Q36286134 | Delays and loss to follow-up before treatment of drug-resistant tuberculosis following implementation of Xpert MTB/RIF in South Africa: A retrospective cohort study |
| Q28487970 | Diagnosis and interim treatment outcomes from the first cohort of multidrug-resistant tuberculosis patients in Tanzania |
| Q34340867 | Diagnostic delays and clinical decision making with centralized Xpert MTB/RIF testing in Durban, South Africa |
| Q36182135 | Early Outcomes Of Decentralized Care for Rifampicin-Resistant Tuberculosis in Johannesburg, South Africa: An Observational Cohort Study |
| Q34076574 | Effects of introducing Xpert MTB/RIF test on multi-drug resistant tuberculosis diagnosis in KwaZulu-Natal South Africa |
| Q64228305 | Estratégias de controle e atenção à tuberculose multirresistente: uma revisão da literature |
| Q40103606 | Evaluation of a nurse practitioner-physician task-sharing model for multidrug-resistant tuberculosis in South Africa |
| Q36281279 | Has universal screening with Xpert® MTB/RIF increased the proportion of multidrug-resistant tuberculosis cases diagnosed in a routine operational setting? |
| Q33576421 | Health system factors influencing management of multidrug-resistant tuberculosis in four European Union countries - learning from country experiences |
| Q28394564 | Impact of Decentralized Care and the Xpert MTB/RIF Test on Rifampicin-Resistant Tuberculosis Treatment Initiation in Khayelitsha, South Africa |
| Q60044348 | Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa |
| Q28547001 | Integrating Community-Based Interventions to Reverse the Convergent TB/HIV Epidemics in Rural South Africa |
| Q38115280 | Integration of HIV and Tuberculosis in the Community |
| Q33446895 | KS-Detect - Validation of Solar Thermal PCR for the Diagnosis of Kaposi's Sarcoma Using Pseudo-Biopsy Samples |
| Q38383242 | Predictors of cure among HIV co-infected multidrug-resistant TB patients at Sizwe Tropical Disease Hospital Johannesburg, South Africa |
| Q89531441 | Provider perspectives of the introduction and implementation of care for drug-resistant tuberculosis patients in district-level facilities in South Africa: a qualitative study |
| Q23909492 | Rapid impact of effective treatment on transmission of multidrug-resistant tuberculosis |
| Q34524569 | Research on implementation of interventions in tuberculosis control in low- and middle-income countries: a systematic review |
| Q42701720 | Spatial distribution of extensively drug-resistant tuberculosis (XDR TB) patients in KwaZulu-Natal, South Africa |
| Q92474275 | Successful expansion of community-based drug-resistant TB care in rural Eswatini - a retrospective cohort study |
| Q28551772 | The effect of early versus late treatment initiation after diagnosis on the outcomes of patients treated for multidrug-resistant tuberculosis: a systematic review |
| Q29247880 | The effect of the Xpert MTB/RIF test on the time to MDR-TB treatment initiation in a rural setting: a cohort study in South Africa’s Eastern Cape Province |
| Q36123235 | The socioeconomic impact of multidrug resistant tuberculosis on patients: results from Ethiopia, Indonesia and Kazakhstan |
| Q37712247 | The treatment journey of a patient with multidrug-resistant tuberculosis in South Africa: is it patient-centred? |
Search more.